We are excited about our new collaboration with Oncodesign Presicion Medicine

Feb 23, 2026 | Press releases, Short news

Oncodesign Precision Medicine and Ksilink join forces to test the Nanocyclix® chemical library in cell models derived from patients with serious central nervous system diseases. Please find the press release here

Share This